Basis of Presentation and Summary of Significant Accounting Policies (Details)
€ in Thousands |
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
|
Dec. 20, 2023
USD ($)
country
milestonePayment
product
shares
|
May 09, 2023
EUR (€)
product
|
Dec. 14, 2017 |
May 31, 2026
product
|
Oct. 31, 2024
USD ($)
milestonePayment
product
|
Jun. 30, 2023
USD ($)
|
Jun. 30, 2026
USD ($)
shares
|
Jun. 30, 2025
USD ($)
shares
|
Jun. 30, 2026
USD ($)
segment
product
reportingUnit
shares
|
Jun. 30, 2025
USD ($)
shares
|
Dec. 31, 2025
USD ($)
|
Dec. 20, 2023
EUR (€)
milestonePayment
country
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of reportable segments | segment |
|
|
|
|
|
|
|
|
1
|
|
|
|
| Number of operating segments | segment |
|
|
|
|
|
|
|
|
1
|
|
|
|
| Tariff receivable |
|
|
|
|
|
|
$ 1,949,000
|
|
$ 1,949,000
|
|
|
|
| Reduction in selling, general and administrative expense |
|
|
|
|
|
|
316,000
|
|
$ 316,000
|
|
|
|
| Number of reporting units | reportingUnit |
|
|
|
|
|
|
|
|
1
|
|
|
|
| Impairment of goodwill |
|
|
|
|
|
|
|
|
$ 0
|
$ 0
|
|
|
| Number of milestone payment | milestonePayment |
2
|
|
|
|
|
|
|
|
|
|
|
2
|
| Non-cash in-process research and development expense |
$ 4,429,000
|
|
|
|
|
|
|
|
|
|
|
|
| Impairment of intangible assets |
|
|
|
|
|
|
|
|
0
|
0
|
|
|
| Accrued revenue contract liabilities |
|
|
|
|
|
|
11,586,000
|
|
11,586,000
|
|
$ 11,548,000
|
|
| Rebates and coupons, credits and payments |
|
|
|
|
|
|
12,837,000
|
$ 10,157,000
|
21,879,000
|
20,318,000
|
|
|
| Payments for provisions for accrued volume-based rebate and coupon liability |
|
|
|
|
|
|
9,870,000
|
8,726,000
|
21,842,000
|
26,046,000
|
|
|
| Contract with customer, liability, revenue recognized |
|
|
|
|
|
|
|
|
9,942,000
|
13,833,000
|
|
|
| Allowance for credit losses |
|
|
|
|
|
|
4,915,000
|
|
4,915,000
|
|
$ 5,289,000
|
|
| Provision for bad debts |
|
|
|
|
|
|
652,000
|
703,000
|
914,000
|
1,754,000
|
|
|
| Write-offs, net of recoveries |
|
|
|
|
|
|
615,000
|
54,000
|
1,288,000
|
936,000
|
|
|
| Income (benefit) expense |
|
|
|
|
|
|
(154,000)
|
$ 53,000
|
102,000
|
$ 125,000
|
|
|
| IEEPA Tariff Refund |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Tariff refunds |
|
|
|
|
|
|
1,051,000
|
|
1,051,000
|
|
|
|
| Reduction in inventory |
|
|
|
|
|
|
$ 582,000
|
|
$ 582,000
|
|
|
|
| Stock Options |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Securities excluded from the computation of diluted net loss per share (in shares) | shares |
|
|
|
|
|
|
6,789,707
|
6,558,707
|
6,789,707
|
6,558,707
|
|
|
| Unvested Restricted Stock Units |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Securities excluded from the computation of diluted net loss per share (in shares) | shares |
|
|
|
|
|
|
6,729,856
|
2,931,829
|
6,729,856
|
2,931,829
|
|
|
| Performance Restricted Stock Units (PRSU) |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Expected dividend yield rate |
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
| Evolus, Inc. | SCH |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Period of termination of first commercial sale |
|
|
10 years
|
|
|
|
|
|
|
|
|
|
| Distribution rights |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Useful lives of intangible assets |
|
|
|
|
|
|
20 years
|
|
20 years
|
|
|
|
| Software, Internally Developed |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Useful lives of intangible assets |
|
|
|
|
|
|
2 years
|
|
2 years
|
|
|
|
| Symatese U.S. Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Contingent milestone payment | € |
|
€ 16,200
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, initial payment | € |
|
€ 4,100
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, initial payment due, period |
|
30 days
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement payment, June 2025 | € |
|
€ 1,600
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement payment, June 2026 | € |
|
4,100
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement payment, June 2027 | € |
|
3,200
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement payment, June 2028 | € |
|
€ 3,200
|
|
|
|
|
|
|
|
|
|
|
| Annual payment triggered, number of products with regulatory approval | product |
|
3
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, upfront payment |
|
|
|
|
|
$ 4,441,000
|
|
|
|
|
|
|
| Regulatory approval not achieved, number of products | product |
|
|
|
|
|
|
|
|
3
|
|
|
|
| License, supply and distribution agreement, annual milestone payment |
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
| License, supply and distribution agreement, initial term |
|
15 years
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, renewal term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
| Symatese Europe Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of products launched | product |
|
|
|
4
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement payment, June 2026 | € |
|
|
|
|
|
|
|
|
|
|
|
€ 1,200
|
| License, supply and distribution agreement payment, June 2027 | € |
|
|
|
|
|
|
|
|
|
|
|
€ 1,900
|
| License, supply and distribution agreement, initial term |
15 years
|
|
|
|
|
|
|
|
|
|
|
|
| Number of countries use aesthetics and dermatological fields | country |
50
|
|
|
|
|
|
|
|
|
|
|
50
|
| Number of milestone payment | milestonePayment |
2
|
|
|
|
2
|
|
|
|
|
|
|
2
|
| Annual net revenue |
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Pending regulatory approval, number of products | product |
3
|
|
|
|
|
|
|
|
|
|
|
|
| Regulatory approval, number of products | product |
|
|
|
|
3
|
|
|
|
|
|
|
|
| Milestone payment, payable period |
|
|
|
|
2 years
|
|
|
|
|
|
|
|
| Symatese Europe Agreement | First Milestone Payment |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, liability, noncurrent |
|
|
|
|
$ 1,035,000
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, intangible asset |
|
|
|
|
1,035,000
|
|
|
|
|
|
|
|
| Symatese Europe Agreement | Second Milestone Payment |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, liability, noncurrent |
|
|
|
|
1,200,000
|
|
|
|
|
|
|
|
| License, supply and distribution agreement, intangible asset |
|
|
|
|
$ 1,200,000
|
|
|
|
|
|
|
|
| Symatese Europe Agreement | Distribution Rights, Evolysse Nasolabial Fold Product |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Finite-live intangible assets capitalized |
$ 1,476,000
|
|
|
|
|
|
|
|
|
|
|
|
| Useful lives of intangible assets |
15 years
|
|
|
|
|
|
15 years
|
|
15 years
|
|
|
15 years
|
| Symatese Europe Agreement | Distribution Rights, Evolysse Products |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Useful lives of intangible assets |
|
|
|
|
|
|
14 years 2 months
|
|
14 years 2 months
|
|
|
|
| Symatese Europe Agreement | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued in exchange for license, supply, and distribution agreement (in shares) | shares |
610,000
|
|
|
|
|
|
|
|
|
|
|
|
| Computers |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, plant and equipment, useful life |
|
|
|
|
|
|
3 years
|
|
3 years
|
|
|
|
| Furniture and Marketing Fixtures |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, plant and equipment, useful life |
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|
| Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Accounts receivable, credit card transaction, converted to cash, period |
|
|
|
|
|
|
|
|
2 days
|
|
|
|
| Minimum | Equipment |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, plant and equipment, useful life |
|
|
|
|
|
|
3 years
|
|
3 years
|
|
|
|
| Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Accounts receivable, credit card transaction, converted to cash, period |
|
|
|
|
|
|
|
|
4 days
|
|
|
|
| Maximum | Equipment |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, Plant, and Equipment [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Property, plant and equipment, useful life |
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|